Stock CANF CAN-FITE BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Can-Fite BioPharma Ltd. Nyse

Equities

CANF

US13471N1028

End-of-day quote Nyse
Other stock markets
 23:00:00 04/02/2024 GMT 		5-day change 1st Jan Change
2.02 USD -3.35% Intraday chart for Can-Fite BioPharma Ltd. -4.04% -8.18%
06-24 Can-Fite Announces Breakthrough Findings Demonstrate Namodenoson Anti-Cancer and Protective Effect Mechanism in the Liver CI
06-10 Can-Fite Biopharma Ltd. Receives IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study CI

Chart calendar Can-Fite BioPharma Ltd.

ef5d49d7c5691230685b454.VgTgl6UCflmyiWMm4zWQWfVqq9qDFdmBpwWHBFNuvkY.F2G__ZxuLTH1v1RJlwXBEJ8cm5y6X57NylXoYgMMxi4EaZn51WZOLIvOJg~011965984dd3f1b12d87cd79e4c6e721

Upcoming events on Can-Fite BioPharma Ltd.

Today 13:00 Annual General Meeting
28/08/2024 Q2 2024 Earnings Release (Projected)
28/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Can-Fite BioPharma Ltd.

06/06/2024 21:15 Business Update Call
02/06/2024 Bio International Convention
29/05/2024 Q1 2024 Earnings Release (Projected)
01/05/2024 23:00 Planet MicroCap Showcase
09/04/2024 21:30 LD Micro Invitational Conference
28/03/2024 11:00 Q4 2023 Earnings Release
17/03/2024 BioEurope Spring Conference
25/01/2024 14:00 Sequire Investor Summit
30/11/2023 12:00 Q3 2023 Earnings Release
10/10/2023 Bio Japan Conference
26/09/2023 AACR Conference
11/09/2023 05:00 H.C. Wainwright Global Investment Conference
06/09/2023 Emerging Growth Conference
31/08/2023 12:00 Q2 2023 Earnings Release
10/08/2023 Emerging Growth Conference
03/08/2023 American Society of Clinical Oncology Meeting
13/07/2023 16:25 Emerging Growth Conference
01/06/2023 12:00 Q1 2023 Earnings Release
13/05/2023 Bio Equity Europe Conference
30/03/2023 12:15 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2,03
1,80
12.89%		0,76
1,10
-30.64%		0,85
0,90
-5.15%		0,81
1,41
-42.7%		0,74
0,80
-7.13%
0,90

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-12,0
-10,8
-11.14%		-14,1
-12,9
-9.6%		-12,8
-12,4
-3.49%		-10,1
-13,9
27.17%		-8,20
-8,30
1.27%
-8,18

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,59
-11,4
15.9%		-14,4
-13,2
-9.42%		-12,6
-12,2
-2.99%		-10,2
-9,20
-10.58%		-7,63
-7,90
3.37%
-9,10

Net income
Million USD		Released
Forecast
Spread 		-9,59
-11,4
15.9%		-14,4
-13,9
-3.91%		-12,6
-12,1
-4.42%		-10,2
-14,2
28.14%		-7,63
-7,90
3.37%
-7,88

EPS
ILS		Released
Forecast
Spread 		-0,39
-0,48
17.7%		-0,13
-0,13
-0.17%		-0,10
-0,06
-55.9%		-0,04
-0,05
30.56%		-0,04
-0,04
0.76%
0,00

Announcement Date27/03/2025/03/2124/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,20
0,27
-23.5%		0,21
0,20
2.5%		0,20
0,25
-18.4%		0,20
0,30
-32%		0,20
0,50
-60.6%		0,20
0,00
- 		0,20
0,20
-2%		0,20
0,20
-2%		0,16
0,20
-22.5%
0,30


0,30


0,30


0,30

EBIT
Million USD		Released
Forecast
Spread 		-4,03
-3,60
-11.89%		-2,37
-3,05
22.3%		-2,07
-2,55
18.82%		-2,57
-2,98
13.51%		-3,08
-3,40
9.32%


-1,78
-2,90
38.48%		-1,87
-1,80
-3.61%		-1,83
-1,90
3.47%
-1,90


-2,10


-2,40


-2,80

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,12
-3,75
-9.81%		-2,43
-3,02
19.27%		-2,19
-2,30
4.74%		-2,53
-1,90
-33.11%		-3,02
-2,00
-50.95%


-1,67
-2,70
38.15%		-1,76
-1,70
-3.65%		-1,65
-1,90
13.05%
-1,90


-2,10


-2,40


-2,70

Net income
Million USD		Released
Forecast
Spread 		-4,12
-3,58
-14.92%		-2,43
-3,02
19.27%		-2,19
-2,50
12.36%		-2,53
-2,93
13.54%		-3,02
-3,45
12.49%


-1,67
-2,80
40.36%		-1,76
-1,70
-3.65%		-1,65
-1,90
13.05%
-1,90


-2,10


-2,40


-2,70

EPS
ILS		Released
Forecast
Spread 		-0,03
-0,03
-3.94%		0,00
0,00
- 		0,00
0,00
- 		-0,03
0,00
- 		0,00
-0,02
-


0,00
0,00
- 		0,00
0,00
- 		-0,04
0,00
-
0,00


0,00


0,00


0,00

Announcement Date24/03/2226/05/2225/08/2225/11/2230/03/2301/06/2331/08/2330/11/2328/03/24----

Upcoming sector events for Can-Fite BioPharma Ltd.

11/07/2024 07:00 BONESUPPORT HOLDING AB: Q2 2024 Earnings Release
15/07/2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release
22/07/2024 BIOGEN INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 07:00 BIOGAIA AB: Q2 2024 Earnings Release
23/07/2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected)
24/07/2024 PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected)
24/07/2024 GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 06:00 UCB: Q2 2024 Earnings Release
25/07/2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected)
29/07/2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Can-Fite BioPharma Ltd.

23/05/2024 10:43 CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release
14/05/2024 16:35 GRIFOLS, S.A.: Q1 2024 Earnings Release
13/05/2024 NATURECELL CO.,LTD.: Q1 2024 Earnings Release
09/05/2024 PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release
09/05/2024 MEDY-TOX INC.: Q1 2024 Earnings Release
09/05/2024 21:05 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release
09/05/2024 07:30 NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
08/05/2024 HUGEL, INC.: Q1 2024 Earnings Release
08/05/2024 21:16 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CANF Stock
  4. CANF Stock
  5. Calendar Can-Fite BioPharma Ltd.